Breaking News
Get 50% Off 0
🧩 Based on my current watchlist, how should I diversify my portfolio?
Ask WarrenAI
Close

InspireMD Inc (NSPR)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow InspireMD's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
2.420 +0.030    +1.26%
08/08 - Closed. Currency in USD
After Hours
2.391
-0.024
-0.994%
22:27:09 - Real-time Data
Type:  Equity
Market:  United States
  • Volume: 49,023
  • Bid/Ask: 0.000 / 0.000
  • Day's Range: 2.357 - 2.495
InspireMD 2.420 +0.030 +1.26%

InspireMD Inc Company Profile

 
Get an in-depth profile of InspireMD Inc, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryHealthcare Equipment & Supplies
SectorHealthcare
Employees

86

Equity Type

ORD

InspireMD, Inc., a medical device company, focuses on the development and commercialization of products for the treatment of carotid artery and other vascular diseases in Europe, Latin America, the Middle East, and the Asia Pacific. The company offers CGuard carotid embolic prevention system (EPS) for use in carotid artery applications; CGuard Prime Stent System, a mesh-covered self-expanding carotid stent; and SwitchGuard neuroprotection system for transcarotid access and neuro protection, as well as treating acute stroke with tandem lesions. It has a strategic agreement with Jacobs Institute to execute an early feasibility study of CGuard Prime for the treatment of acute stroke patients with tandem lesions. The company sells its products through local distribution partners. InspireMD, Inc. was founded in 2005 and is headquartered in Miami, Florida.

Contact Information

Address 6303 Waterford District Drive Suite 215
Miami, 33126
United States
Phone 888 776 6804
Fax -

Top Executives

Name Age Since Title
Alexandre A. Abizaid - - Member of Advisory Board
Antonio Colombo - - Member of Advisory Board
Yaron Almagor - - Member of Advisory Board
Martin B. Leon - - Member of Advisory Board
Eberhart Grube - - Member of Advisory Board
Paul S. Stuka 70 2011 Independent Chairman of the Board
Marvin L. Slosman 61 2020 President, CEO & Director
Dariusz Dudek - - Member of Advisory Board
Bernhard Reimers - 2018 Member of Advisory Board
Gregg W. Stone 68 - Member of Advisory Board
Michael Berman 67 2013 Independent Director
Ralf Kolvenbach - 2018 Member of Advisory Board
Adnan H. Siddiqui - 2022 Member of Scientific Advisory Board & Strategic Advisor
Thomas J. Kester 78 2016 Independent Director
Kathryn Arnold 50 2021 Independent Director
Piotr Musialek - 2018 Member of Advisory Board
Alberto Cremonesi - 2018 Member of Advisory Board
Gary S. Roubin 76 2020 Independent Director
Kenneth Rosenfield - 2021 Chair of Scientific Advisory Board
Scott Raymond Ward 65 2024 Independent Director
Raymond W. Cohen 66 2025 Director
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

NSPR Comments

Write your thoughts about InspireMD Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email